Circulating Tumor Cells in Gastrointestinal Malignancies: Current Techniques and Clinical Implications

by Georg Lurje, Marc Schiesser, Andreas Claudius Hoffmann, Paul Magnus Schneider
Published 2010-01-01

EGFR, FLT1 and heparanase as markers identifying patients at risk of short survival in cholangiocarcinoma.

by Andreas-Claudius Hoffmann, Eray Goekkurt, Peter V Danenberg, Sylvia Lehmann, Gerhard Ehninger, Daniela E Aust, Jan Stoehlmacher-Williams
Published 2013-01-01

Circulating Tumor Cell Composition in Renal Cell Carcinoma.

by Ivonne Nel, Thomas C Gauler, Kira Bublitz, Lazaros Lazaridis, André Goergens, Bernd Giebel, Martin Schuler, Andreas-Claudius Hoffmann
Published 2016-01-01

Detection of circulating tumor cell subpopulations in patients with head and neck squamous cell carcinoma (HNSCC).

by Patrick Weller, Ivonne Nel, Philipp Hassenkamp, Thomas Gauler, Anke Schlueter, Stephan Lang, Paulette Dountsop, Andreas-Claudius Hoffmann, Götz Lehnerdt
Published 2014-01-01

MDR1 and ERCC1 Expression Predict Outcome of Patients with Locally Advanced Bladder Cancer Receiving Adjuvant Chemotherapy

by Andreas-Claudius Hoffmann, Peter Wild, Christina Leicht, Simone Bertz, Kathleen D. Danenberg, Peter V. Danenberg, Robert Stöhr, Michael Stöckle, Jan Lehmann, Martin Schuler, Arndt Hartmann
Published 2010-08-01

High Expression of HIF1a Is a Predictor of Clinical Outcome in Patients with Pancreatic Ductal Adenocarcinomas and Correlated to PDGFA, VEGF, and bFGF

by Andreas-Claudius Hoffmann, Ryutaro Mori, Daniel Vallbohmer, Jan Brabender, Ellen Klein, Uta Drebber, Stephan E. Baldus, Janine Cooc, Mizutomo Azuma, Ralf Metzger, Arnulf H. Hoelscher, Kathleen D. Danenberg, Klaus L Prenzel, Peter V. Danenberg
Published 2008-07-01